Dynavax is paying $30 million upfront for global rights to Vaxart’s investigational oral COVID-19 vaccine candidate, positioning the biotech to see phase 2b data before placing a bigger bet on the ...
The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin cancer who were ...
It's officially the season of text prompts and phone call reminders to get your seasonal vaccines. Cases of flu, RSV, COVID-19, and other common respiratory illnesses tend to spike as temperatures go ...
This is read by an automated voice. Please report any issues or inconsistencies here. The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients — revving up their ...
Covid-19 vaccines, credited with saving millions of lives during the pandemic, set off a powerful alarm that rallies the human immune system against cancer and nearly doubles the median survival ...
TipRanks on MSN
Vaxart Partners with Dynavax for Oral COVID-19 Vaccine
Vaxart ( ($VXRT) ) has shared an announcement. On November 4, 2025, Vaxart entered into an exclusive license and collaboration agreement with ...
Ask scientist Nowras Rahhal about his cutting-edge work on a COVID-19 vaccine and he is eager to explain the complexities, ...
GREEN BAY, Wis. (WBAY) - Local residents are expressing confusion over COVID-19 vaccine guidance for children. A viewer contacted Action 2 News, saying they were struggling to get a vaccine for their ...
As two fellow New Yorkers with mutual colleagues outside of basketball, Stephen A. Smith and Kyrie Irving have butt heads for as long as the NBA point guard has been in the league. Since Irving’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback